Aurora Spine Corporation (ASG.V)
CAD 0.43
(1.18%)
CAD 0.43
(1.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -446.19 Thousand USD | 4.71% |
| 2022 | -1.56 Million USD | 42.08% |
| 2021 | -2.7 Million USD | -116.56% |
| 2020 | -1.25 Million USD | 0.19% |
| 2019 | -1.25 Million USD | -2132.52% |
| 2018 | -56.14 Thousand USD | 97.59% |
| 2017 | -2.32 Million USD | -38.5% |
| 2016 | -1.67 Million USD | 46.2% |
| 2015 | -3.12 Million USD | 58.42% |
| 2014 | -7.5 Million USD | 0.0% |
| 2012 | -1.44 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -222.32 Thousand USD | 6.63% |
| 2024 Q2 | -111.64 Thousand USD | 49.78% |
| 2024 Q3 | 114.46 Thousand USD | 202.53% |
| 2023 Q2 | -435.41 Thousand USD | 34.32% |
| 2023 Q4 | -238.1 Thousand USD | -19.23% |
| 2023 Q3 | -199.7 Thousand USD | 54.13% |
| 2023 FY | -1.49 Million USD | 4.71% |
| 2023 Q1 | -662.93 Thousand USD | 21.04% |
| 2022 Q2 | -227.5 Thousand USD | 41.15% |
| 2022 Q1 | -386.57 Thousand USD | 57.24% |
| 2022 Q4 | -839.56 Thousand USD | -625.94% |
| 2022 FY | -1.56 Million USD | 42.08% |
| 2022 Q3 | -115.65 Thousand USD | 49.16% |
| 2021 FY | -2.7 Million USD | -116.56% |
| 2021 Q1 | -561.81 Thousand USD | -13.06% |
| 2021 Q3 | -368.21 Thousand USD | 57.94% |
| 2021 Q4 | -903.96 Thousand USD | -145.5% |
| 2021 Q2 | -875.47 Thousand USD | -55.83% |
| 2020 Q2 | -184.84 Thousand USD | 67.02% |
| 2020 Q4 | -496.92 Thousand USD | -5544.25% |
| 2020 FY | -1.25 Million USD | 0.19% |
| 2020 Q3 | -8804.00 USD | 95.24% |
| 2020 Q1 | -560.54 Thousand USD | 4.53% |
| 2019 Q2 | -44.1 Thousand USD | 78.47% |
| 2019 FY | -1.25 Million USD | -2132.52% |
| 2019 Q4 | -587.16 Thousand USD | -40.67% |
| 2019 Q3 | -417.39 Thousand USD | -846.38% |
| 2019 Q1 | -204.81 Thousand USD | -197.33% |
| 2018 Q4 | -68.88 Thousand USD | -148.41% |
| 2018 FY | -56.14 Thousand USD | 97.59% |
| 2018 Q1 | -161.25 Thousand USD | 82.49% |
| 2018 Q2 | 31.69 Thousand USD | 119.65% |
| 2018 Q3 | 142.29 Thousand USD | 348.98% |
| 2017 Q1 | -620.32 Thousand USD | 10.65% |
| 2017 FY | -2.32 Million USD | -38.5% |
| 2017 Q2 | -456.12 Thousand USD | 26.47% |
| 2017 Q4 | -920.87 Thousand USD | -180.43% |
| 2017 Q3 | -328.38 Thousand USD | 28.01% |
| 2016 Q1 | -306.21 Thousand USD | 60.85% |
| 2016 Q3 | -523 Thousand USD | -235.71% |
| 2016 Q4 | -694.23 Thousand USD | -32.74% |
| 2016 Q2 | -155.79 Thousand USD | 49.12% |
| 2016 FY | -1.67 Million USD | 46.2% |
| 2015 Q4 | -782.17 Thousand USD | -27.16% |
| 2015 Q3 | -615.12 Thousand USD | -40.05% |
| 2015 FY | -3.12 Million USD | 58.42% |
| 2015 Q2 | -439.21 Thousand USD | 65.82% |
| 2015 Q1 | -1.28 Million USD | 45.05% |
| 2014 Q1 | -1.27 Million USD | 0.0% |
| 2014 Q2 | -1.5 Million USD | -17.54% |
| 2014 Q3 | -2.38 Million USD | -59.05% |
| 2014 Q4 | -2.33 Million USD | 2.11% |
| 2014 FY | -7.5 Million USD | 0.0% |
| 2013 Q3 | -643.93 Thousand USD | 0.0% |
| 2012 FY | -1.44 Million USD | 0.0% |
| 2012 Q3 | -261.61 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -20.72 Million CAD | 97.848% |
| Therma Bright Inc. | -3.6 Million CAD | 87.616% |
| Theralase Technologies Inc. | -4.59 Million CAD | 90.288% |
| VentriPoint Diagnostics Ltd. | -4.93 Million CAD | 90.95% |